- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-02-0012766

Max Medikit Labs Private Limited
About Max Medikit Labs Private Limited
Data last updated:
Max Medikit Labs Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2014PTC265672. Its GSTIN is 07AAJCM1130H1ZS (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Shanker and Daya Shankar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Office No – 41 Plot No – 113 & 31 34/433 Veer Savarkar Block Main Road Vikas Marg Del, Hi 110092, Delhi, India – 110092.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.81 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1,825 (net margin 0.6%) and EBITDA of ₹2.39 Lakh (EBITDA margin 84.7%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 24% over five years.
Max Medikit Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0012766). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Max Medikit Labs
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No – 41 Plot No – 113 & 31 34/433 Veer Savarkar Block Main Road Vikas Marg Del, Hi 110092, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Max Medikit Labs Private Limited
The main business activity of Max Medikit Labs is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Max Medikit Labs Private Limited FY 2022 filings available
Max Medikit Labs Private Limited reported revenue of ₹2.81 Lakh (up 17% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Max Medikit Labs Private Limited
Revenue rose 17% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 24%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Max Medikit Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,825 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Max Medikit Labs Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 84.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Max Medikit Labs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Max Medikit Labs Private Limited
Max Medikit Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Shanker | Director | 01 Mar 2014 | 12 Years 7 Months | Current |
| Daya Shankar | Director | 01 Mar 2014 | 12 Years 7 Months | Current |
Peer Comparison of Max Medikit Labs Private Limited
Max Medikit Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanrajtosh Pharmaceutical Private Limited | ₹2.86 Lakh (FY 2025) | •••• | •••• | -51.0% | •••• | Panchkula, Haryana, India |
| Aimcare Pharmaceuticals Private Limited | ₹2.86 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | New Delhi, Delhi, India |
| Infinity Unicorns Private Limited | ₹2.86 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Derabassi, Punjab, India |
| Panacea Pharma Private Limited | ₹2.84 Lakh (FY 2020) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Leehpl Ventures Private Limited | ₹2.83 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Nagpur, Maharashtra, India |
| Max Medikit Labs Private Limited this company | ₹2.81 Lakh (FY 2022) | •••• | •••• | 17.0% | •••• | Delhi, India |
| Seawoods Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Roldac Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2023) | •••• | •••• | -64.0% | •••• | Dehradun, Uttarakhand, India |
| Vitabiotics Biomass Pharma Private Limited | ₹2.8 Lakh (FY 2025) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Hopnext Wellness Private Limited | ₹2.78 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Bathinda, Punjab, India |
| Chemixal Pharmaceuticals Private Limited | ₹2.78 Lakh (FY 2020) | •••• | •••• | 264.0% | •••• | Kota, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Max Medikit Labs by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Max Medikit Labs Private Limited
Max Medikit Labs Private Limited is audited by K R A P S & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K R A P S & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Max Medikit Labs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Max Medikit Labs Private Limited
Max Medikit Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Max Medikit Labs Private Limited
Employment history and EPFO contributions of people linked to Max Medikit Labs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Max Medikit Labs Private Limited
Max Medikit Labs Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Daya Shankar was appointed as Director on 01 Mar 2014.
Credit Ratings, Litigation & Regulatory Alerts for Max Medikit Labs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Max Medikit Labs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Max Medikit Labs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Max Medikit Labs Private Limited
Max Medikit Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM1130H1ZS | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Max Medikit Labs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Max Medikit Labs Private Limited
Max Medikit Labs is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 March 2014 (12+ years old) and is registered under CIN U33110DL2014PTC265672.
Max Medikit Labs reported revenue of ₹2.81 Lakh for FY 2022 (up 17% YoY).
Max Medikit Labs has 2 current directors:
- Ravi Shanker - Director
- Daya Shankar - Director
Max Medikit Labs reported a net profit of ₹1,825 (net margin 0.6%) and EBITDA of ₹2.39 Lakh (EBITDA margin 84.7%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Max Medikit Labs is -52% over three years and -24% over five years. In the latest year (FY 2022) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Max Medikit Labs is 07AAJCM1130H1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of Max Medikit Labs is U33110DL2014PTC265672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Max Medikit Labs was incorporated on 01 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Max Medikit Labs by revenue are Sanrajtosh Pharmaceutical Private Limited, Aimcare Pharmaceuticals Private Limited, Infinity Unicorns Private Limited, Panacea Pharma Private Limited, Leehpl Ventures Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Daya Shankar was appointed as Director on 01 Mar 2014. Ravi Shanker was appointed as Director on 01 Mar 2014.
Yes, Max Medikit Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0012766).